menu search

Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)

89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...

October 21, 2023, 12:48 pm

Should value investors buy comp en de mn cemig (cig) stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...

October 16, 2023, 11:18 am

Regeneron to showcase progress from innovative oncology portfolio in several difficult-to-treat cancers at esmo

Event-free survival of investigational use of Libtayo® (cemiplimab) in neoadjuvant cutaneous squamous ...

October 15, 2023, 10:05 pm

Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at obesityweek®

– CT-388 administered once-weekly resulted in clinically meaningful weight loss and insulin sensitivity over a 4 week treatment period in participan...

October 15, 2023, 4:00 pm

3 utility stocks to buy for resisting market volatility

Invest in utility stocks like Telefonica Brasil (VIV), Pampa Energia (PAM) and cemiG (CIG) for steady r...

October 12, 2023, 9:46 am

Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)

– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocal...

October 10, 2023, 11:30 am

Looking for a growth stock? 3 reasons why cemig (cig) is a solid choice

cemig (CIG) is well positioned to outperform the market, as it exhibits above-average growth in financi...

September 22, 2023, 2:17 pm

Seelos therapeutics' stock slides 36% after trial of treatment for suicidal ideation has too few patients to meet endpoint

Seelos Therapeutics Inc.'s stock SEEL tumbled 36% in premarket trade Wednesday, after the company reported promising results from a trial of a treatme...

September 20, 2023, 7:46 am

Xeris biopharma achieves shipping milestone for hypoglycemia treatment gvoke

Xeris Biopharma said it has shipped more than 1 million units of Gvoke, its ready-to-use liquid glucagon for the treatment of severe hypogly...

July 31, 2023, 9:44 am

Global agave syrup market to top a valuation of us$ 1,092.2 million by 2033 amid rising demand for sugar alternatives | future market insights inc.

The Agave Syrup Market is thriving due to the increasing popularity of sugar alternatives. Consumers are increasingly seeking healthier and natural sw...

July 27, 2023, 12:30 am

Bridgebio pharma: positive attr-cm treatment data leads to other 2023 catalysts

Primary endpoint met in BridgeBio Pharma, Inc.'s phase 3 ATTRibute-CM study, which used acoramidis for the treatment of patients with transthyretin am...

July 17, 2023, 6:42 pm

cemig: great business but uncertain future

Brazilian power company cemig has seen a significant recovery since 2019, with operational expenses and...

July 14, 2023, 2:30 pm

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Fda approves eli lilly and boehringer ingelheim's jardiance for children 10 and older with type 2 diabetes

The U.S. Food and Drug Administration has approved the use of Jardiance 10 mg and 25 mg tables to lower blood sugar along with diet and exercise in ch...

June 21, 2023, 1:29 pm


Search within

Pages Search Results: